title: Role of stromal-derived factor-1<alpha>/CXCR4 in neo-intimal repair.
abstract: Neo-intimal hyperplasia is one of the major causes of restenosis in which stromal cell-derived factor-1<alpha> (SDF-1α) and its receptor CXCR4 play an important role. In a rat common carotid artery balloon injury model, the number of CD34(+)CXCR4(+) cells was significantly increased immediately after injury (p < 0.01), followed by a gradual decrease to baseline seven days after the injury. Furthermore, the plasma (SDF-1α) level was markedly elevated, and peaked 24 hours after injury (p < 0.01), followed by a rapid decrease to baseline level seven days after the injury. In the injured common carotid artery, the mRNA expression of (SDF-1α) was elevated immediately after injury, followed by a gradual decline, but that of CXCR4 was increased four days after injury. Immuno-histochemistry displayed CXCR4-positive staining one day after injury, which then gradually increased and continued for at least one month. In addition, administration of AMD3100 (200 ng/kg, i.p.), a CXCR4 antagonist, did not affect the number of CD34(+)CXCR4(+) cells, the elevated level of plasma (SDF-1α) and expression of (SDF-1α) mRNA.  The expression of CXCR4 mRNA and protein however was markedly decreased, and detectable CXCR4-positive cells occurred four days after injury, followed by a decreased intensity of staining. We also found that, three months after balloon injury, stenosis of the carotid artery intima in the group that received AMD3100 was significantly less than in the untreated group (p < 0.05). Therefore, (SDF-1α)/CXCR4 played a crucial role in the intimal hyperplasia, and restenosis may have be attenuated after inhibition of CD34(+)CXCR4(+) cells in the intima.
authors.affiliation: Department of Geriatrics, 9th Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
authors.forename: J
authors.initials: J
authors.lastname: Sheng
authors.forename: W-W
authors.initials: WW
authors.lastname: Cai
authors.forename: N-Y
authors.initials: NY
authors.lastname: Fang
authors.forename: S-Q
authors.initials: SQ
authors.lastname: Wang
authors.forename: J-J
authors.initials: JJ
authors.lastname: Wu
mesh_terms: D000818:Animals; D001596:Benzylamines; D020212:Carotid Artery Injuries / Q000378:metabolism*; D017536:Carotid Artery, Common; D054377:Chemokine CXCL12 / Q000378:metabolism*; D000080027:Cyclams; D004195:Disease Models, Animal; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D006965:Hyperplasia / Q000378:metabolism / Q000517:prevention & control; D007150:Immunohistochemistry; D008297:Male; D058426:Neointima / Q000378:metabolism*; D012333:RNA, Messenger / Q000032:analysis*; D051381:Rats; D017207:Rats, Sprague-Dawley; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D017539:Tunica Intima / Q000378:metabolism*
chemical_list: D001596:Benzylamines; D054377:Chemokine CXCL12; C486264:Cxcr4 protein, rat; D000080027:Cyclams; D006571:Heterocyclic Compounds; D012333:RNA, Messenger; D019718:Receptors, CXCR4; C088327:plerixafor